Showing results (151-160 of 5,589) with videos related to
Sort By:
Pageof 559
Clinical and Experimental Immunology|August 27, 2015
Anti-CD20 monoclonal antibody-dependent phagocytosis of chronic lymphocytic leukaemia cells by autologous macrophagesA K Church, K R VanDerMeid, N A Baig, et al.American Journal of Clinical Oncology|October 16, 1999
Phase II study of 2-chlorodeoxyadenosine in combination with chlorambucil in previously untreated B-cell chronic lymphocytic leukemiaA Tefferi, R Levitt, C Y Li, et al.Blood|January 28, 1999
Long-term survival (10 years or more) in 30 patients with primary amyloidosisR A Kyle, M A Gertz, P R Greipp, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trialT E Witzig, L Letendre, J Gerstner, et al.Archives of Pathology & Laboratory Medicine|August 1, 1994
Bone marrow aspirate immunofluorescent and bone marrow biopsy immunoperoxidase staining of plasma cells in histologically occult plasma cell proliferative marrow disordersD M Menke, P R Greipp, G Colon-Otero, et al.Blood|August 1, 1995
True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 casesJ D Hoyer, C W Ross, C Y Li, et al.Leukemia|November 5, 2004
A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myelomaA Dispenzieri, G A Wiseman, M Q Lacy, et al.Leukemia|June 4, 2010
Relationship between elevated immunoglobulin free light chain and the presence of IgH translocations in multiple myelomaS Kumar, L Zhang, A Dispenzieri, et al.Leukemia|November 28, 2012
Serum free light chain ratio as a biomarker for high-risk smoldering multiple myelomaJ T Larsen, S K Kumar, A Dispenzieri, et al.Leukemia|September 6, 2013
Relationship between initial clinical presentation and the molecular cytogenetic classification of myelomaA J Greenberg, S V Rajkumar, T M Therneau, et al.Pageof 559